Kjeld Schmiegelow: Clinical Trials

6 trials sponsored by Kjeld Schmiegelow, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed, 1 withdrawn. 3 Not applicable, 2 Phase 1, 2 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 2, Completed 1
Phase 12Completed 1, Withdrawn 1
Phase 22Completed 1, Withdrawn 1
Phase 41Unknown 1

Follow Kjeld Schmiegelow: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer
Early termination of empirical antibiotics - Neutropenia, Febrile, Pediatric Cancer
Not applicableCompletedKjeld Schmiegelow932020-11-202025-04-09
Thiopurine EnhAnced Maintenance Therapy
Thioguanine (oral) - Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Phase 1 / Phase 2CompletedKjeld Schmiegelow302016-10-012020-04-15
Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma
6-thioguanine - Non-Hodgkin Lymphoma
Phase 1 / Phase 2WithdrawnKjeld Schmiegelow2014-07-012016-10-07
Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid
Xaluprine, Puri-Nethol - Acute Lymphoblastic Leukemia, 6-mercaptopurine Therapy
Phase 4UnknownKjeld Schmiegelow162013-06-012018-04-20
Rehabilitation Including Social Activity and Education in Children and Teenagers With Cancer
Intervention group - Childhood Cancer
Not applicableUnknownKjeld Schmiegelow2402013-01-012013-02-07
Rehabilitation Including Social and Physical Activity in Children and Teenagers With Cancer
Intervention group - Childhood Cancer
Not applicableUnknownKjeld Schmiegelow2402013-01-012013-02-07

Conditions studied

Neoplasms (4)  ·  Motor Activity (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Febrile Neutropenia (1)  ·  Lymphoma, Non-Hodgkin (1)

Interventions

Mercaptopurine (2)  ·  Thioguanine (2)  ·  Methotrexate (1)

Countries

Denmark (6)

Top investigators

Nadja Vissing, MD, PhD (1)

Results publications

PMID 24229362, PMID 26872002, PMID 32624004, PMID 28761697, PMID 29741279, PMID 32519032, PMID 41990768